Perspectives About Online Information
2026年6月2日 更新者：NYU Langone Health
The purpose of this research study is to understand the perspectives of U.S. adults on online information about prostate cancer.
Study participants will receive different online information about prostate cancer to view such as a video post or text post, and complete a one-time online survey that will take approximately 10 minutes.
研究概览
地位
尚未招聘
条件
研究类型
介入性
注册 (估计的)
3200
阶段
- 不适用
联系人和位置
本节提供了进行研究的人员的详细联系信息，以及有关进行该研究的地点的信息。
学习联系方式
- 姓名：Nataliya Byrne
- 电话号码：646-501-2681
- 邮箱：Nataliya.byrne@nyulangone.org
研究联系人备份
- 姓名：Stacy Loeb, MD, MSc, PhD
- 电话号码：646-825-6300
- 邮箱：Stacy.loeb@nyulangone.org
学习地点
-
-
New York
-
New York、New York、美国、10016
- NYU Langone Health
-
-
参与标准
研究人员寻找符合特定描述的人，称为资格标准。这些标准的一些例子是一个人的一般健康状况或先前的治疗。
资格标准
适合学习的年龄
- 成人
- 年长者
接受健康志愿者
是的
描述
Inclusion Criteria:
- U.S. adult age 40+ who identifies as Black and/or Hispanic
- Enrolled in Dynata online survey panel
- Willing and able to participate in the research study.
Exclusion Criteria:
- Individuals up to age 39
- Individuals living outside the U.S.
- Individuals who are not Black and/or Hispanic
学习计划
本节提供研究计划的详细信息，包括研究的设计方式和研究的衡量标准。
研究是如何设计的？
设计细节
- 主要用途：其他
- 分配：随机化
- 介入模型：单组作业
- 屏蔽：单身的
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的：Prostate Cancer Post with Video
Participants will receive a survey and be asked their perspective after reviewing a prostate cancer post with video
|
Participants will review a post about prostate cancer.
The survey will include questions about demographics and internet use.
It may also provide participants with resources about online information.
|
|
实验性的：Prostate Cancer Post without Video
Participants will receive a survey and be asked their perspective after reviewing a prostate cancer post without video.
|
The survey will include questions about demographics and internet use.
It may also provide participants with resources about online information.
Participants will review a post about prostate cancer.
|
研究衡量的是什么？
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Trust in the post, as measured by a 4-point Likert scale
大体时间：Post-intervention (~5 minutes)
|
A single question is asked of "How much do you trust the information in the post?"
Participants used a 4-point Likert scale from 1 (trust the information completely) to 4 (Did not trust the information).
Scores range from 1-4, with higher scores indicating less trust.
|
Post-intervention (~5 minutes)
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Short-form Positive and Negative Affect Schedule (PANAS) Positive Score
大体时间：Post-intervention (~5 minutes)
|
The Short-form Positive and Negative Affect Schedule (PANAS-SF) is a brief, 10-item psychometric tool used to assess two distinct emotional dimensions: Positive Affect (e.g., active, inspired) and Negative Affect (e.g., upset, afraid).
Respondents rate each of the 10 adjectives on a 5-point Likert scale.
Scores can range from 10 - 50, with higher scores representing higher levels of positive affect.
|
Post-intervention (~5 minutes)
|
|
Short-form Positive and Negative Affect Schedule (PANAS) Negative Score
大体时间：Post-intervention (~5 minutes)
|
The Short-form Positive and Negative Affect Schedule (PANAS-SF) is a brief, 10-item psychometric tool used to assess two distinct emotional dimensions: Positive Affect (e.g., active, inspired) and Negative Affect (e.g., upset, afraid).
Respondents rate each of the 10 adjectives on a 5-point Likert scale.
Scores can range from 10 - 50, with lower scores representing lower levels of negative affect.
|
Post-intervention (~5 minutes)
|
合作者和调查者
在这里您可以找到参与这项研究的人员和组织。
调查人员
- 首席研究员：Stacy Loeb, MD, MSc, PhD、NYU Langone Health
研究记录日期
这些日期跟踪向 ClinicalTrials.gov 提交研究记录和摘要结果的进度。研究记录和报告的结果由国家医学图书馆 (NLM) 审查，以确保它们在发布到公共网站之前符合特定的质量控制标准。
研究主要日期
学习开始 (估计的)
2026年7月1日
初级完成 (估计的)
2028年1月31日
研究完成 (估计的)
2028年1月31日
研究注册日期
首次提交
2026年6月2日
首先提交符合 QC 标准的
2026年6月2日
首次发布 (实际的)
2026年6月8日
研究记录更新
最后更新发布 (实际的)
2026年6月8日
上次提交的符合 QC 标准的更新
2026年6月2日
最后验证
2026年6月1日
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 25-01456
- 1R01CA278997 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)？
是的
IPD 计划说明
The de-identified participant data from the final research dataset will be shared upon reasonable request beginning 9 to 36 months after publication or as required by a condition of awards or supporting agreements, provided the requesting investigator executes a data use agreement with NYU Langone Health.
This instance of data sharing will also require separate IRB review as well as review from NYU Langone's Data Sharing Strategy Board (DSSB).
Requests should be directed to: stacy.loeb@nyulangone.org.
The protocol and statistical analysis plan will be posted on Clinicaltrials.gov
only as required by federal regulation or supporting awards and agreements.
IPD 共享时间框架
Beginning 9 months and ending 36 months following article publication or as required by a condition of awards and agreements supporting the research.
IPD 共享访问标准
The investigator who proposed to use the data after signing a data use agreement will be granted access upon reasonable request for biomedical research purposes.
Requests should be directed to stacy.loeb@nyulangone.org.
To gain access, data requestors will need to sign a data access agreement.
IPD 共享支持信息类型
- 研究方案
- 树液
药物和器械信息、研究文件
研究美国 FDA 监管的药品
不
研究美国 FDA 监管的设备产品
不
此信息直接从 clinicaltrials.gov 网站检索，没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求，请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改，我们的网站上也会自动更新.